Business
GenTech Acquires Emerging Supplement Leader American Metabolix, Adding Keto Innovator to Growing Portfolio of Sports Nutrition Brands
GenTech Acquires Emerging Supplement Leader American Metabolix, Adding Keto Innovator to Growing Portfolio of Sports Nutrition Brands.
About this update from Gentech Holdings Inc.
[{"type":"text","content":"Wheat Ridge, Colorado--(Newsfile Corp. - September 2, 2021) - GenTech Holdings, Inc. (OTC Pink: GTEH) (\"GenTech\" or the \"Company\") (www.gentechholdings.com), an emerging leader in the Functional Foods (www.sinfitnutrition.com) marketplace, is excited to announce that it has acquired American Metabolix (www.AmericanMetabolix.com), one of the fastest growing supplement companies in the world, with sports nutrition and Keto products available at GNC, Bodybuilding.com, and top sports nutrition retailers worldwide.GenTech has recently acquired and mobilized a number of new brands and businesses, including Sinfit Nutrition, Fizzique, MPB Snacks, NXT Bar, Nature Soothie, and Yourganics, all of which are now commercially active, with many major awards and wide distribution, including exposure in major retail marketplaces.American Metabolix adds another blue chip to this marquee list. American Metabolix products have sold in over 550 brick and mortar locations across multiple countries, including the United States, New Zealand, Australia, and Russia, among others. The company was founded in 2012 by Jason Duran and Markus Trillsch, both of whom have established themselves as experienced innovators in the sports supplement industry, developing multiple disruptive brands and products.American Metabolix has gone on to win awards in every relevant category in its market space as a sports nutrition and supplements brand. According to documents from the company, American Metabolix has produced approximately $400k in sales since early Feb, and is on track to exceed $1 million in 2021 revenues.Management notes that August revenues across all of GenTech’s recent roll-up acquisitions, including American Metabolix, add up to an annualized run rate of more than $2.3 million on the top line, not including any growth curve extrapolation.\"American Metabolix is a heavyweight addition to our roll-up portfolio, presenting significant individual value and growth as well as multiple synergies within the context of our ecosystem of functional foods products,\" noted GenTech CEO David Lovatt. \"By rolling up a wide range of promising brands targeting different niches in the same broad category of the retail market, we will be able to dramatically improve the profit potential of each product line through synergies in marketing, distribution, packagin...